Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Advocacy groups Friday cheered the new list of selected drugs and urged the Trump administration to continue the negotiations. Some Republicans have called for ending or overhauling the initiative ...

“Every time a new list (of drugs) comes out ... Ofev, which treats idiopathic pulmonary fibrosis. • Linzess, which treats chronic idiopathic constipation and irritable bowel syndrome with ...

Speaking over the HMPV virus cases, the Chairman of PSRI Institute of Pulmonary, Critical Care & Sleep Medicine, Dr Gopi Chand Khilnani said the situation this time is not similar to situation that we ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

The list for the next round of medicines that will ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.